Available for individuals undergoing serious and complicated surgeries, Trasylol aprotinin from Bayer, is used to reduce blood loss.The major benefit of the drug during such delicate surgeries is the slowing down of fibrinolysis the process that leads to the breakdown of blood clots. It decreases the need for blood transfusions during surgery, as well as preventing major organ damage by preventing a drop in blood pressure.While Aprotinin was available as early as the 1960s, it did not see wide usage in its most recent capacity until it was picked up, patented, and aggressively marketed by the Bayer Corporation as Trasylol towards the end of the 1980s. It was originally used to treat acute pancreatitis where it inhibited enzymes in the pancreas. It was however, not used widely as a blood loss drug within extensive surgical procedures until the late 1960s.Aprotinin quickly became a highly sought after replacement drug for aminocaproic acid after Bayer funneled funds into the development of the blood loss aid. Routinely, patients undergoing major surgeries involving potential blood transfusions, sustained bleeding, or large amounts of blood loss have been given aminocaproic acid, with a relatively low rate of drug-induced mortality.In fact, the largest risk […]

Full Article At: KnowHow-Now.com Articles

Bookmark to: